Guaifensin and Codeine Phosphate Oral Solution USP CV

Manufacturer
Proficient Rx LP
Effective date
2019-12-01
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:55:42

Label at a glance#

ProductGuaifenesin and Codeine Phosphate
Active ingredientGuaifenesin, Codeine Phosphate
Label structure11 sections

Dosage and administration

Take orally as stated below or use as directed by a physician. Adults and children 12 years of age and over: 10 mL (2 teaspoonfuls) every 4 hours, not to exceed 12 teaspoonfuls in a 24-hour period; Children 6 to under 12 years: 5 mL (1 teaspoonful) every 4 hours, not to exceed 6 teaspoonfuls in a 24-hour period; Children under 6 years: consult a physician. A special measuring device should be used to give an accur...

Storage and handling

Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). [See USP] Protect from light.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Each 5 mL (1 teaspoonful) contains Guaifenesin, USP 100 mg and Codeine Phosphate, USP 10 mg.

Inactive Ingredients: Citric acid, edetate disodium, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, flavor, glycerin, menthol, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium saccharin, and sorbitol.

Sodium Content: 5 mg/5 mL

Under federal law, Guaifenesin and Codeine Phosphate Oral Solution USP is available without a prescription. Certain state laws may differ.

Click here to enter text.

OTC - ACTIVE INGREDIENT SECTION

[Enter Active Ingredient here]

INACTIVE INGREDIENT SECTION

[Enter Inactive Ingredients here]

ACTIONS

SPL UNCLASSIFIED SECTION

This product combines the expectorant, guaifenesin, with the cough suppressant, codeine. Guaifenesin enhances the output of lower respiratory tract fluid. The enhanced flow of less viscid secretions promotes and facilitates the removal of mucus. Codeine is a centrally acting agent which elevates the threshold for cough.

As a result, dry, unproductive coughs become more productive and less frequent.

Click here to enter text.

OTC - PURPOSE SECTION

[Enter Purpose here]

INDICATIONS

INDICATIONS & USAGE SECTION

Temporarily controls cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants. Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Hypersensitivity to any of the ingredients.

WARNINGS

WARNINGS SECTION

A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash or persistent headache, consult a physician. Do not take this product for persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, emphysema, or if cough is accompanied by excessive phlegm (mucus) unless directed by a physician. Adults and children who have a chronic pulmonary disease or shortness of breath, or children who are taking other drugs, should not take this product unless directed by a physician. May cause or aggravate constipation. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Professional Note: Guaifenesin has been shown to produce a color interference with certain clinical laboratory determinations of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).

Click here to enter text.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

[Enter Keep Out of Reach of Children here]

DRUG INTERACTION PRECAUTION

SPL UNCLASSIFIED SECTION

Caution should be used when taking this product with sedatives, tranquilizers and drugs used for depression, especially monoamine oxidase inhibitors (MAOIs). These combinations may cause greater sedation (drowsiness) than is caused by the products used alone. (See WARNINGS)

DOSAGE and ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Take orally as stated below or use as directed by a physician. Adults and children 12 years of age and over: 10 mL (2 teaspoonfuls) every 4 hours, not to exceed 12 teaspoonfuls in a 24-hour period; Children 6 to under 12 years: 5 mL (1 teaspoonful) every 4 hours, not to exceed 6 teaspoonfuls in a 24-hour period; Children under 6 years: consult a physician. A special measuring device should be used to give an accurate dose of this product to children under 6 years of age. Giving a higher dose than recommended by a physician could result in serious side effects for a child. Use of codeine-containing preparations is not recommended for children under 2 years of age. Do not exceed recommended dosage.

STORAGE

STORAGE AND HANDLING SECTION

Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). [See USP] Protect from light.

HOW SUPPLIED

SPL UNCLASSIFIED SECTION

Guaifenesin and Codeine Phosphate Oral Solution USP (red color-cherry flavor) is supplied in the following oral dosage forms: NDC 63187-117-12 (4 fl oz bottle).

SPL UNCLASSIFIED SECTION

Pharmaceutical
Associates, Inc.
Greenville, SC 29605

R08/06

Repackaged by:
Proficient Rx LP
Thousand Oaks, CA 91320

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

63187-117-04
63187-117-04

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0121-0775-04ML - Milliliter0121-0775ac9f8c15-4f02-4667-b975-5c20f7d93dab12012-07-24
0121-0775-08ML - Milliliter0121-0775ef3933a2-ccb0-4b44-977e-b6b8f9f14e1212018-02-20
0121-0775-16ML - Milliliter0121-0775270b5b4b-ceb0-4155-ad98-6b3454cf2a2912012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Codeine PhosphateACTIVE INGREDIENTGSL05Y1MN61
GuaifenesinACTIVE INGREDIENT495W7451VQ1
CODEINE ANHYDROUSACTIVE MOIETYUX6OWY2V7J1
GuaifenesinACTIVE MOIETY495W7451VQ1
CITRIC ACID ACETATEINACTIVE INGREDIENTDSO12WL7AU1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63187-11763187-117-04
0121-0775

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
aee81c13-c681-4790-b5a8-e3bc32f97e6d49e75518-f02b-4251-8239-c71c3376cadc2024-10-01WarningsExact identifier
spl set id: 49e75518-f02b-4251-8239-c71c3376cadc
Guaifenesin and Codeine PhosphateGUAIFENESIN AND CODEINE PHOSPHATEPAI Holdings, LLC88d0994c-4270-4408-8837-bd97510b21182024-09-06WarningsExact identifier
ndc (product): 0121-0775

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.